Fig. 1From: Targeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloproliferative neoplasmsSchematic representation of the distribution of mutations in molecules associated with cytokine signaling in Ph-ve MPNs. The approximate average values are shownBack to article page